Filing Details

Accession Number:
0001567619-19-023141
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-16 16:12:35
Reporting Period:
2019-12-12
Accepted Time:
2019-12-16 16:12:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Aduro Biotech Inc. ADRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193201 T Stephen Isaacs C/O Aduro Biotech, Inc.
740 Heinz Avenue
Berkeley CA 94710
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-12 5,897 $1.16 290,029 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,932 Indirect By Family Trust
Footnotes
  1. The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The shares owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.